Back to references

Treefrog’s PMDA pathway for cell therapy, mapped.

Treefrog's PMDA pathway for cell therapy, mapped.

Treefrog Therapeutics asked PMC to map the PMDA pathway for its cell therapy platform before committing to a Japanese subsidiary.

Our team translated regulatory milestones into an operating plan: evidence gaps, local partner sequencing, and the documentation rhythm Japanese reviewers expect.

The result was a clear route from feasibility to filing readiness — without losing momentum on the broader Asia strategy.

Regenerative Medicine